Skip to main content
Equibles
MBOT logo

MBOT · Microbot Medical Inc. · Metrics

Track MBOT — free

Use MBOT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research MBOT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.15 +0.08 (+7.69%) At close · Oct 7
Rebalance outlook locked
Market Cap
$75.22M
Shares
67.16M
Volume · Oct 7 649.79K Avg daily vol (3M) 656.96K

MBOT metrics

59 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$1.07
Market cap
$75.22M

Price action

20 metrics
Price change (1W)
-14.1%
Price change (30D)
-28.7%
Price change (3M)
-43.7%
Price change (6M)
-53.3%
Price change (YTD)
-46.5%
Price change (1Y)
-66.8%
Trailing year
Price change (5Y)
-85.2%
52-week high
$3.29
52-week low
$1.07
Change from 52-week high
-67.5%
Change from 52-week low
+0.0%
Annualized volatility
68.6%
Annualized volatility (3M)
48.5%
Beta
1.8
RSI (14D)
15.6
Price vs SMA 50
-28.3%
Price vs SMA 200
-45.0%
Avg volume (3M)
656,956
Relative volume
3.0
Average dollar volume
$1.01M

Company

3 metrics
Sector
Healthcare
Industry
Medical Devices
Shares outstanding
67.16M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
751.4×
reciprocal yield 0.1%
P / book
1.2
reciprocal yield 80.5%
FCF yield
-20.9%
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
-19.1%

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
—

Profitability

9 metrics
Gross margin
—
Operating margin
782.8%
Trailing 12 months
Net margin
-787.9%
Gross profit (TTM)
$853,922
Operating profit (TTM)
−$18.51M
Net income (TTM)
−$16.34M
Trailing 12 months
Diluted EPS (TTM)
$-0.24
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$1.15

Growth

11 metrics
Revenue growth YoY
—
Year over year
Net income growth YoY
—
Revenue (TTM)
$113,966
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+84.1%
Year over year · more shares
Revenue CAGR (3Y)
-56.0%
Revenue CAGR (5Y)
-39.4%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
-23.7%
Return on assets
-22.3%
Debt / equity
—
Current ratio
18.6
EBITDA (TTM)
−$18.46M
Free cash flow (TTM)
−$17.93M
Quick ratio
17.8
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$3.15M
Total assets
$73.36M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
−$17.64M
Capital expenditures (TTM)
$288,000
R&D (TTM)
$5.87M
SG&A (TTM)
$12.00M
Stock compensation (TTM)
$1.22M
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
72
13F filer change QoQ
-9
Institutional ownership
17.4%

Short interest

3 metrics
Short interest
10.5%
Latest settlement · 18.2 days to cover
Days to cover
18.2d
Short-squeeze score
67 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 883975 CUSIP 59503A204 13F (30d) 2 filings 2 filers Visit website Investor relations